Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1634/stemcells.2008-0496 http://repositorio.unifesp.br/handle/11600/31128 |
Resumo: | Progressive renal failure continues to be a challenge. the use of bone marrow cells represents a means of meeting that challenge. We used lineage-negative (Lin(-)) cells to test the hypothesis that Lin(-) cell treatment decreases renal injury. Syngeneic Fischer 344 rats were divided into four groups: sham ( laparotomy only, untreated); Nx (five-sixth nephrectomy and untreated); NxLC1 (five-sixth nephrectomy and receiving 2 x 10(6) Lin(-) cells on postnephrectomy day 15); and NxLC3 (five-sixth nephrectomy and receiving 2 x 10(6) Lin(-) cells on postnephrectomy days 15, 30, and 45). On postoperative day 16, renal mRNA expression of interleukin (IL)-1 beta, tumor necrosis factor-alpha, and IL-6 was lower in NxLC rats than in Nx rats. On postnephrectomy day 60, NxLC rats presented less proteinuria, glomerulosclerosis, anemia, renal infiltration of immune cells, and protein expression of monocyte chemoattractant protein-1, as well as decreased interstitial area. Immunostaining for proliferating cell nuclear antigen showed that, in comparison with sham rats, Nx rats presented greater cell proliferation, whereas NxLC1 rats and NxLC3 rats presented less cell proliferation than did Nx rats. Protein expression of the cyclin-dependent kinase inhibitor p21 and of vascular endothelial growth factor increased after nephrectomy and decreased after Lin(-) cell treatment. On postnephrectomy day 120, renal function (inulin clearance) was significantly better in Lin(-) cell-treated rats than in untreated rats. Lin(-) cell treatment significantly improved survival. These data suggest that Lin(-) cell treatment protects against chronic renal failure. STEM CELLS 2009; 27: 682-692 |
id |
UFSP_79d6f79d39f10ca908da4f9812c0929f |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/31128 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal FailureHematopoietic stem cellsNephrectomyKidney failureChronic proteinuriaFibrosis/pathologyProliferating cell nuclear antigenProgressive renal failure continues to be a challenge. the use of bone marrow cells represents a means of meeting that challenge. We used lineage-negative (Lin(-)) cells to test the hypothesis that Lin(-) cell treatment decreases renal injury. Syngeneic Fischer 344 rats were divided into four groups: sham ( laparotomy only, untreated); Nx (five-sixth nephrectomy and untreated); NxLC1 (five-sixth nephrectomy and receiving 2 x 10(6) Lin(-) cells on postnephrectomy day 15); and NxLC3 (five-sixth nephrectomy and receiving 2 x 10(6) Lin(-) cells on postnephrectomy days 15, 30, and 45). On postoperative day 16, renal mRNA expression of interleukin (IL)-1 beta, tumor necrosis factor-alpha, and IL-6 was lower in NxLC rats than in Nx rats. On postnephrectomy day 60, NxLC rats presented less proteinuria, glomerulosclerosis, anemia, renal infiltration of immune cells, and protein expression of monocyte chemoattractant protein-1, as well as decreased interstitial area. Immunostaining for proliferating cell nuclear antigen showed that, in comparison with sham rats, Nx rats presented greater cell proliferation, whereas NxLC1 rats and NxLC3 rats presented less cell proliferation than did Nx rats. Protein expression of the cyclin-dependent kinase inhibitor p21 and of vascular endothelial growth factor increased after nephrectomy and decreased after Lin(-) cell treatment. On postnephrectomy day 120, renal function (inulin clearance) was significantly better in Lin(-) cell-treated rats than in untreated rats. Lin(-) cell treatment significantly improved survival. These data suggest that Lin(-) cell treatment protects against chronic renal failure. STEM CELLS 2009; 27: 682-692Univ São Paulo, Sch Med, Fac Med,Lab Pesquisa Basica LIM 12, Dept Nephrol, BR-01246903 São Paulo, BrazilUniversidade Federal de São Paulo, Dept Nephrol, São Paulo, BrazilUniv São Paulo, Dept Immunol, BR-01246903 São Paulo, BrazilUniversidade Federal de São Paulo, Dept Nephrol, São Paulo, BrazilWeb of ScienceAlphamed PressUniversidade de São Paulo (USP)Universidade Federal de São Paulo (UNIFESP)Alexandre, Cristianne SilvaVolpini, Rildo AparecidoShimizu, Maria HeloisaSanches, Talita RojasSemedo, Patricia [UNIFESP]Di Jura, Vera LuciaCamara, Niels Olsen [UNIFESP]Seguro, Antonio CarlosAndrade, Lucia2016-01-24T13:52:01Z2016-01-24T13:52:01Z2009-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion682-692http://dx.doi.org/10.1634/stemcells.2008-0496Stem Cells. Durham: Alphamed Press, v. 27, n. 3, p. 682-692, 2009.10.1634/stemcells.2008-04961066-5099http://repositorio.unifesp.br/handle/11600/31128WOS:000264706900019engStem Cellsinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2016-01-24T11:52:01Zoai:repositorio.unifesp.br/:11600/31128Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652016-01-24T11:52:01Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure |
title |
Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure |
spellingShingle |
Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure Alexandre, Cristianne Silva Hematopoietic stem cells Nephrectomy Kidney failure Chronic proteinuria Fibrosis/pathology Proliferating cell nuclear antigen |
title_short |
Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure |
title_full |
Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure |
title_fullStr |
Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure |
title_full_unstemmed |
Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure |
title_sort |
Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure |
author |
Alexandre, Cristianne Silva |
author_facet |
Alexandre, Cristianne Silva Volpini, Rildo Aparecido Shimizu, Maria Heloisa Sanches, Talita Rojas Semedo, Patricia [UNIFESP] Di Jura, Vera Lucia Camara, Niels Olsen [UNIFESP] Seguro, Antonio Carlos Andrade, Lucia |
author_role |
author |
author2 |
Volpini, Rildo Aparecido Shimizu, Maria Heloisa Sanches, Talita Rojas Semedo, Patricia [UNIFESP] Di Jura, Vera Lucia Camara, Niels Olsen [UNIFESP] Seguro, Antonio Carlos Andrade, Lucia |
author2_role |
author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade de São Paulo (USP) Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Alexandre, Cristianne Silva Volpini, Rildo Aparecido Shimizu, Maria Heloisa Sanches, Talita Rojas Semedo, Patricia [UNIFESP] Di Jura, Vera Lucia Camara, Niels Olsen [UNIFESP] Seguro, Antonio Carlos Andrade, Lucia |
dc.subject.por.fl_str_mv |
Hematopoietic stem cells Nephrectomy Kidney failure Chronic proteinuria Fibrosis/pathology Proliferating cell nuclear antigen |
topic |
Hematopoietic stem cells Nephrectomy Kidney failure Chronic proteinuria Fibrosis/pathology Proliferating cell nuclear antigen |
description |
Progressive renal failure continues to be a challenge. the use of bone marrow cells represents a means of meeting that challenge. We used lineage-negative (Lin(-)) cells to test the hypothesis that Lin(-) cell treatment decreases renal injury. Syngeneic Fischer 344 rats were divided into four groups: sham ( laparotomy only, untreated); Nx (five-sixth nephrectomy and untreated); NxLC1 (five-sixth nephrectomy and receiving 2 x 10(6) Lin(-) cells on postnephrectomy day 15); and NxLC3 (five-sixth nephrectomy and receiving 2 x 10(6) Lin(-) cells on postnephrectomy days 15, 30, and 45). On postoperative day 16, renal mRNA expression of interleukin (IL)-1 beta, tumor necrosis factor-alpha, and IL-6 was lower in NxLC rats than in Nx rats. On postnephrectomy day 60, NxLC rats presented less proteinuria, glomerulosclerosis, anemia, renal infiltration of immune cells, and protein expression of monocyte chemoattractant protein-1, as well as decreased interstitial area. Immunostaining for proliferating cell nuclear antigen showed that, in comparison with sham rats, Nx rats presented greater cell proliferation, whereas NxLC1 rats and NxLC3 rats presented less cell proliferation than did Nx rats. Protein expression of the cyclin-dependent kinase inhibitor p21 and of vascular endothelial growth factor increased after nephrectomy and decreased after Lin(-) cell treatment. On postnephrectomy day 120, renal function (inulin clearance) was significantly better in Lin(-) cell-treated rats than in untreated rats. Lin(-) cell treatment significantly improved survival. These data suggest that Lin(-) cell treatment protects against chronic renal failure. STEM CELLS 2009; 27: 682-692 |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-01-01 2016-01-24T13:52:01Z 2016-01-24T13:52:01Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1634/stemcells.2008-0496 Stem Cells. Durham: Alphamed Press, v. 27, n. 3, p. 682-692, 2009. 10.1634/stemcells.2008-0496 1066-5099 http://repositorio.unifesp.br/handle/11600/31128 WOS:000264706900019 |
url |
http://dx.doi.org/10.1634/stemcells.2008-0496 http://repositorio.unifesp.br/handle/11600/31128 |
identifier_str_mv |
Stem Cells. Durham: Alphamed Press, v. 27, n. 3, p. 682-692, 2009. 10.1634/stemcells.2008-0496 1066-5099 WOS:000264706900019 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Stem Cells |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
682-692 |
dc.publisher.none.fl_str_mv |
Alphamed Press |
publisher.none.fl_str_mv |
Alphamed Press |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268404079525888 |